En Es
Categories

Industry News

Hologic Showcased Latest Advances at Virtual ECR Congress 2020

By HospiMedica International staff writers
20 Aug 2020

IllustrationHologic, Inc. (Marlborough, MA, USA) showcased its latest advances and shared its new innovations on its virtual booth at the online ECR 2020 event held on July 15-21.

ECR 2020 was the first ever online congress to be held by the European Society of Radiology (ESR) due to the COVID-19 pandemic and attracted a record 15,265 professional delegates from over 130 countries. The Virtual Exhibition was attended by 216 companies which demonstrated their products, hosted webinars and invited attendees to visit their very own digital booths. Hologic also used its virtual booth at ECR 2020 to demonstrate how the company’s clinically proven, integrated solutions incorporating artificial intelligence (AI) can support management of patients across the breast health continuum of care.

At ECR 2020, Hologic demonstrated its Unifi Workspace solution which integrates reading of MRI, ultrasound and mammography into one dedicated platform, and is designed to allow for more efficient review of breast images. The company also showcased its 3DQuorum Imaging Technology, Powered by Genius AI, which significantly reduces mammography exam reading times without compromising image quality, sensitivity or accuracy.
Also on display at Hologic’s virtual booth at ECR 2020 was the company’s Faxitron Path+ Specimen Radiography System which enables pathologists to image a wide range of specimens of varying sizes and have immediate access to high-definition X-ray images, directly in the pathology lab. Hologic also demonstrated its Faxitron Trident HD Specimen Radiography System which delivers enhanced image quality, improved workflow and instant sample verification during breast-conserving surgeries and stereotactic breast biopsies.

Among other innovations showcased at ECR 2020 by Hologic was the LOCalizer Wireless Radio Frequency Identification (RFID) Breast Lesion Localization System, a non-radioactive, radiofrequency localization system designed for precise marking and targeting of lesions in breast-conserving surgery. Attendees to Hologic’s virtual booth at ECR 2020 also got a glimpse of the company’s new Aixplorer Mach 30 Breast Ultrasound System which provides fast, high quality imaging and is the first to offer an intuitive touchpad control and large adjustable touchscreen display.

Related Links:

Hologic, Inc.



E-mail Print
FaceBook Twitter Google+ Linked in

Hologic

Designs and provides products for clinical laboratory and blood screening, including testing items for detection of human diseases, such as tuberculosis, strep throat, pneumonia, and sexually transmitted diseases, as well as for human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV) contamination of blood
More info

More articles about Hologic

20 Oct 2021
Hologic Acquires Bolder Surgical to Expand Surgical Franchise
Hologic, Inc. (Marlborough, MA, USA) is set to acquire Bolder Surgical (Louisville, CO, USA; www.boldersurgical.com), a provider of advanced energy vessel sealing surgical devices, in a deal that will expand its surgical franchise.
Read More
24 Jun 2021
Hologic Completes Acquisition of Mobidiag
Hologic, Inc. (Marlborough, MA, USA) has completed its previously announced acquisition of Mobidiag Ltd. (Espoo, Finland), an innovator in near-patient, acute care molecular diagnostic testing, for an enterprise value of approximately USD 808 million.
Read More
02 Mar 2021
Hologic Acquires European Molecular Diagnostic Company Diagenode
Hologic, Inc. (Marlborough, MA, USA) has acquired Diagenode (Liège, Belgium), a developer and manufacturer of molecular diagnostic assays and epigenetics products, which is expected to diversify its diagnostic business across test menu, customer segments and geography.
Read More
04 Feb 2021
Hologic Partners with Google Cloud to Focus on AI and Machine Learning for Advancing Digital Diagnostic Capabilities
Hologic, Inc. (Marlborough, MA, USA) and Google Cloud have entered into a new agreement to focus on enhancing artificial intelligence (AI) and machine learning (ML) to bring about breakthrough results in cervical cancer screening.
Read More
07 Jan 2021
Hologic to Acquire Diagnostic Tests Provider Biotheranostics
Hologic, Inc. (Marlborough, MA, USA) has agreed to acquire Biotheranostics, Inc. (San Diego, CA, USA), a privately held, commercial-stage company that provides molecular diagnostic tests for breast and metastatic cancers, for approximately USD 230 million.
Read More
05 Jan 2021
Hologic Acquires SOMATEX Medical Technologies
Hologic, Inc. (Marlborough, MA, USA) has completed the acquisition of SOMATEX Medical Technologies GmbH (Berlin, Germany), a leader in biopsy site markers and localization technologies, for approximately USD 64 million.
Read More
02 Dec 2020
Hologic Receives FDA Clearance for Genius AI Detection Technology for Early Breast Cancer Detection
Hologic, Inc. (Marlborough, MA, USA) has received US Food and Drug Administration (FDA) clearance for its Genius AI Detection technology, a new deep learning-based software designed to help radiologists detect subtle potential cancers in breast tomosynthesis images.
Read More
15 Dec 2016
Hologic to Sell Blood-Screening Business to Grifols for USD 1.85 Billion
US medical device maker Hologic, Inc. has agreed to sell off its share of the Procleix blood-screening business to long-time partner, Grifols SA, for USD 1.85 billion in cash.
Read More

Additional news

30 Nov 2022
Global Multiparameter Patient Monitoring Systems Market Driven by Rising Chronic Illnesses
An increase in the number of people suffering from chronic illnesses, combined with an ever-growing elderly population, is expected to help the global multiparameter patient monitoring systems market register a CAGR of 5.8% over the 2022-2028 period to reach USD 15.5 billion by 2028.
Read More
23 Nov 2022
Global Visualization Instruments for MIS Market Driven by Increasing Demand for Endoscopy Procedures
The increasing demand for visualization systems for complex surgical procedures, growing demand for minimally invasive surgeries, and rising prevalence of chronic diseases are expected to help the global visualization instruments for minimally invasive surgery (MIS) market register a CAGR of 7.2% between 2022 and 2031 and reach a value of USD 21 billion by 2031.
Read More
11 Nov 2022
Global Diagnostic ECG Market Driven by Increased Incidence of Cardiac Diseases
The rising prevalence of such chronic conditions is necessitating the need for diagnosis and treatment in order to keep track of the patient's daily medical condition and maintain medical records. This, coupled with rising hospitalization of the older population for the treatment of cardiac diseases, has increased the need for electrocardiograph (ECG) diagnosis.
Read More
11 Nov 2022
Radcal to Supply Quality Assurance X-Ray Testing Equipment to West Physics
Radcal Corporation (Monrovia, CA, USA), a leading manufacturer of diagnostic X-ray quality assurance (QA) meters, has reached an agreement with West Physics (Atlanta, GA, USA), one of the largest and most successful Medical Physics groups in the U.S., to supply QA X-ray testing equipment.
Read More
09 Nov 2022
Leica Biosystems Acquires Cell IDx, Expanding Offerings in Multiplexed Tissue Profiling
Leica Biosystems, a technology leader in automated staining and brightfield and fluorescent imaging (Nussloch, Germany), has acquired Cell IDx, Inc. (San Diego, CA, USA), which provides multiplex staining panels, tissue staining, and imaging and analysis services.
Read More
08 Nov 2022
Global Infusion Pumps Market Driven by Increasing Incidence of Chronic Diseases
Rising demand for ambulatory infusion pumps in home care, increasing incidence of chronic diseases along with a rapid growth of the geriatric population, and growing number of surgical procedures being performed, are driving the growth of the global infusion pumps market. As a result, the market is projected to register a CAGR of 7% from USD 14.7 billion in 2022 to USD 20.5 billion by 2027.
Read More
07 Nov 2022
Mast Group Enters into Multi-Country Distribution Agreement for Nanomix's eLab System
Mast Group Limited (Liverpool, UK) and Nanomix (Emeryville, CA, USA) have entered into a multi-region distribution agreement wherein Mast will market and distribute the Nan?mix eLab system in the UK, Germany, France, Ireland and South Africa.
Read More
07 Nov 2022
AI-Enabled Diagnostic Testing Could Become More Accurate and Reliable than Current Tests
An expanded collaboration between two industry leaders will pave the way for the development of AI-enabled diagnostic testing that is more accurate and reliable than current U.S. tests for patients with chronic diseases, including kidney, cardiovascular, liver and neurologic conditions.
Read More
01 Nov 2022
Global Infectious Respiratory Disease Diagnostics Market Driven by New Multiplex PCR Tests and POC Products
The global infectious respiratory disease diagnostics market size is expected to reach USD 43.6 billion by 2030, driven by an increase in the prevalence of infectious respiratory diseases and initiatives taken by governments & non-profit organizations to introduce novel & innovative products to address the growing demand.
Read More
Copyright © 2000-2022 TradeMed.com. All rights reserved. | Terms And Conditions